Accès ouvert
2026
article
OpenAlex
Savitri Krishnamurthy, Clara Lam, Dhanrajan Tiruchinapalli, Linlin Luo et autres
Context.—: Prevalence data of human epidermal growth factor receptor 2 (HER2)-ultralow (immunohistochemistry [IHC] 0 with membrane staining in ≤10% of cells; HER2 IHC 0+) breast cancer are limited. Objective.—: To evaluate the proportion of HER2-ultralow among metastatic breast cancer samples originally scored …
us, fi, pl, sg, fr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Hannah Barton, Hannah Moore, Rebecca Guy, Clarissa Oeser et autres
OBJECTIVE: To investigate the impact of transition from National Institute for Health and Care Excellence (NICE) guidelines to Kaiser Permanente Neonatal Sepsis Risk Calculator (KP-SRC) on early-onset sepsis (EOS) diagnosis and mortality. STUDY DESIGN: Pre-post intervention analysis across 16 NHS hospital Trusts …
gb, us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Erica L. Mayer, Simon M. Collin, Sam Hillman, Luis C. Berrocal-Almanza et autres
PURPOSE: To investigate real-world demographics, clinical characteristics, treatment patterns, and outcomes in US patients with ≥ 1 line of therapy (LOT) for hormone receptor-positive (HR+) HER2-low metastatic breast cancer (mBC). METHODS: This retrospective cohort study used a US-based electronic health record-derived de-identified …
us, sg, ch, fr
(code pays fourni par la source)
2026
article
OpenAlex
Taynah A R Repsold, Simon M. Collin, Bianca B C Amorim, Liana M M de Sena et autres
BACKGROUND: Hansen's disease (HD, leprosy) had a global incidence of approximately 200 000 new cases per annum over the last decade. Armadillos are recognized reservoirs of Mycobacterium leprae in the Americas and HD is considered a zoonosis in the USA. Our aim …
br, gb
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Savitri Krishnamurthy, Dhanrajan Tiruchinapalli, Clara lam, Simon M. Collin et autres
Abstract Background Based on DESTINY-Breast04 (HER2-low) and -06 (HER2-low/-ultralow) trials, T-DXd is approved for HER2-low (immunohistochemistry [IHC] 1+ or IHC 2+/in situ hybridization negative) or -ultralow (IHC 0 with membrane staining in ≤10% of tumor cells) mBC. Whole slide images (WSIs) from …
us, gb, fr, at, kr, de
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Simon M. Collin, Sam Hillman, Chintal H. Shah, Reema Tank et autres
PURPOSE: To examine real-world treatment patterns and effectiveness among patients with metastatic triple-negative breast cancer (mTNBC) in the United States. DESIGN: Retrospective, observational study using Flatiron Enhanced Datamart electronic health records from patients diagnosed with mTNBC between January 1, 2018, and June …
gb, jp, us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Maria Suau Sans, Amelia Andrews, Luisa K. Hallmaier-Wacker, Thomas Inns et autres
gb, ca
(code pays fourni par la source)
Accès ouvert
2026
review
OpenAlex
Egbert F. Smit, Simon M. Collin, Manoj Prahladan, Flavia Lujan et autres
Interstitial lung disease (ILD) can occur in patients with cancer. ILD can be caused by anti-cancer treatments (drug-induced [DI] ILD), but also by opportunistic infection, and non-drug-related etiologies. This systematic literature review (SLR) investigated the epidemiology and etiology of non-DI ILD and …
Accès ouvert
2025
editorial
OpenAlex
Simon M. Collin, Geneviève Sirois, Paul Zanazanian
LOI 23Ce numéro se distingue sur plusieurs points.Il s'agit du deuxième de nos numéros généraux à contenir un mini-numéro spécial.Et ce mini-numéro spécial est véritablement distinctif, voire sans précédent dans les annales des revues, puisqu'il est le fruit d'une préoccupation partagée et …
ca
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Simon M. Collin, Clara Lam, Simone Treiger Sredni, Zakiya Haji-Noor et autres
PURPOSE: To quantify the proportion of HER2-negative metastatic breast cancers with low or ultralow levels of HER2 expression and identify facilitators and barriers to HER2 testing and reporting in US community settings. METHODS: Analysis of electronic medical record data from a retrospective …
fr, sg, pl, fi, nl, gb, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Manali Bhave, Tiffany A. Traina, Simon M. Collin, Jenny Tse et autres
Background Chemotherapy is the main treatment for patients with metastatic triple-negative breast cancer (mTNBC) who are ineligible for immunotherapy. TNBC is associated with poorer treatment outcomes than other breast cancer subtypes. Objective To evaluate treatment patterns, quantify real-world healthcare costs and assess …
Accès ouvert
2025
article
OpenAlex
Manali Bhave, Tiffany A. Traina, Simon M. Collin, Jenny Tse et autres
Background Chemotherapy is the main treatment for patients with metastatic triple-negative breast cancer (mTNBC) who are ineligible for immunotherapy. TNBC is associated with poorer treatment outcomes than other breast cancer subtypes. Objective To evaluate treatment patterns, quantify real-world healthcare costs and assess …
us, gb, sg
(code pays fourni par la source)